Thu, May 15, 10:33 AM (37 days ago)
**DSwiss, Inc. (DQWS) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** Q1 2025 revenue surged to $1,001,186, up from $471,377 in Q1 2024, indicating strong sales growth. - **Profit Margins:** Gross profit margins slightly decreased to 26.3% in Q1 2025 from 57.3% in Q1 2024 due to higher cost of revenue. - **Net Income:** Net income decreased to $138,736 in Q1 2025 from $177,665 in Q1 2024, despite higher revenue. - **Cash Flow:** Operating cash flow turned negative at -$84,751 in Q1 2025, compared to positive $62,517 in Q1 2024, primarily due to changes in working capital. - **Earnings Changes:** Earnings per share (EPS) decreased to $0.0007 in Q1 2025 from $0.0009 in Q1 2024. **Trends & Uncertainties:** - **Growth:** The company is expanding its client base and product lines, focusing on OEM/ODM services and B2B DNA genotyping services. - **Market Expansion:** DSwiss plans to expand globally through strategic partnerships and leverage social media for marketing. - **Regulatory:** The company must comply with stringent regulations in Malaysia and other markets, which may impact operations. - **Cash Flow:** Negative operating cash flow and significant working capital requirements may pose liquidity challenges. **Future Operations Impact:** - **Investments:** The company plans to invest in capital expenditures and ongoing operations to drive growth. - **Partnerships:** Strategic relationships and partnerships will be crucial for global expansion. - **Regulatory Compliance:** Continued focus on meeting regulatory requirements will be essential for sustained operations. - **Cash Management:** Effective cash management will be vital to address working capital needs and support growth initiatives.